Hoping for more discussion on this abstract #ACR22 #gouterati

@Tuhina_Neogi@twitter.com @ALGaffoRheumMD@twitter.com

RT @kaz_yos@twitter.com

#ACR22 1809. Impact of Colchicine Prophylaxis on Cardiovascular Outcome Among Gout Patients: A Secondary Analysis of CARES Trial. No CV benefit with colchicine 6-month prophylaxis. Too short for this benefit? By Keigo Hayashi.

🐦🔗: https://twitter.com/kaz_yos/status/1591817011705024512

🌟Abs 1678 @tonymerriman2@twitter.com
GWAS revealing new pathogenic pathways in #gout

👉In addition to known pathways (urate regulation, NLRP3 inflammasome and IL-1), CHIP pathway, insulin signalling pathway identified

#goutology #gouterati
#ACR22

#crystaleers #gouterati 😂